Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference

Dec 01, 2015, 13:21 ET from Array BioPharma Inc.

BOULDER, Colo., Dec. 1, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

 

Event:         

Oppenheimer Annual Healthcare Conference

Presenter:    

Ron Squarer, Chief Executive Officer

Date:             

Wednesday, December 9, 2015

Time:             

10:20 a.m. Eastern Time

Webcast:    

http://www.veracast.com/webcasts/opco/healthcare2015/19204383745.cfm

 

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

 

CONTACT: 

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

thaugeto@arraybiopharma.com

 

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com